DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Monores
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
1
球脊髄性筋萎縮症
1
1. 球脊髄性筋萎縮症
臨床試験数
:
18
/
薬物数
:
15
- (
DrugBank
:
8
) /
標的遺伝子数
:
10
-
標的パスウェイ数
:
17
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2010-022558-18-IT
(
EUCTR
)
11/10/2010
20101011
28/09/2012
20120928
A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA).
A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA).
spinal and bulbar muscular atrophy (SBMA)
MedDRA version: 15.0;Level: HLGT;Classification code 10029317;Term: Neuromuscular disorders;System Organ Class: 10029205 - Nervous system disorders
MedDRA version: 15.0;Level: SOC;Classification code 10029205;Term: Nervous system disorders;Level: LLT;Classification code 10047868;Term: Weakness of limbs;System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
MedDRA version: 15.0;Level: PT;Classification code 10013969;Term: Dyspnoea at rest;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
spinal and bulbar muscular atrophy (SBMA)
MedDRA version: 15.0;Level: HLGT;Classification code 10029 ...
Trade Name:
MONORES
*30CPR 20MCG
INN or Proposed INN: Clenbuterol
AZIENDA OSPEDALIERA DI PADOVA
NULL
Authorised-recruitment may be ongoing or finished
Female: no
Male: yes
Italy